267 related articles for article (PubMed ID: 30760284)
1. SKP2 promotes breast cancer tumorigenesis and radiation tolerance through PDCD4 ubiquitination.
Li C; Du L; Ren Y; Liu X; Jiao Q; Cui D; Wen M; Wang C; Wei G; Wang Y; Ji A; Wang Q
J Exp Clin Cancer Res; 2019 Feb; 38(1):76. PubMed ID: 30760284
[TBL] [Abstract][Full Text] [Related]
2. DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation.
Cui H; Wang Q; Lei Z; Feng M; Zhao Z; Wang Y; Wei G
J Exp Clin Cancer Res; 2019 Aug; 38(1):350. PubMed ID: 31409387
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of S-phase kinase-associated protein-2 expression in MCF-7 inhibits cell growth and enhances the cytotoxic effects of epirubicin.
Sun L; Cai L; Yu Y; Meng Q; Cheng X; Zhao Y; Sui G; Zhang F
Acta Biochim Biophys Sin (Shanghai); 2007 Dec; 39(12):999-1007. PubMed ID: 18064393
[TBL] [Abstract][Full Text] [Related]
4. Skp2-macroH2A1-CDK8 axis orchestrates G2/M transition and tumorigenesis.
Xu D; Li CF; Zhang X; Gong Z; Chan CH; Lee SW; Jin G; Rezaeian AH; Han F; Wang J; Yang WL; Feng ZZ; Chen W; Wu CY; Wang YJ; Chow LP; Zhu XF; Zeng YX; Lin HK
Nat Commun; 2015 Mar; 6():6641. PubMed ID: 25818643
[TBL] [Abstract][Full Text] [Related]
5. Cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth.
Zhou L; Yu X; Li M; Gong G; Liu W; Li T; Zuo H; Li W; Gao F; Liu H
EBioMedicine; 2020 Jan; 51():102570. PubMed ID: 31806563
[TBL] [Abstract][Full Text] [Related]
6. Skp2 is over-expressed in breast cancer and promotes breast cancer cell proliferation.
Zhang W; Cao L; Sun Z; Xu J; Tang L; Chen W; Luo J; Yang F; Wang Y; Guan X
Cell Cycle; 2016 May; 15(10):1344-51. PubMed ID: 27111245
[TBL] [Abstract][Full Text] [Related]
7. von Hippel-Lindau protein promotes Skp2 destabilization on DNA damage.
Roe JS; Kim HR; Hwang IY; Cho EJ; Youn HD
Oncogene; 2011 Jul; 30(28):3127-38. PubMed ID: 21358672
[TBL] [Abstract][Full Text] [Related]
8. Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model.
Li X; Yokoyama NN; Zhang S; Ding L; Liu HM; Lilly MB; Mercola D; Zi X
Oncotarget; 2015 Dec; 6(39):41809-24. PubMed ID: 26497688
[TBL] [Abstract][Full Text] [Related]
9. MiRNA-183-5p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting the PDCD4.
Cheng Y; Xiang G; Meng Y; Dong R
Reprod Biol; 2016 Sep; 16(3):225-233. PubMed ID: 27476679
[TBL] [Abstract][Full Text] [Related]
10. Dissection of the APCCdh1-Skp2 cascade in breast cancer.
Fujita T; Liu W; Doihara H; Date H; Wan Y
Clin Cancer Res; 2008 Apr; 14(7):1966-75. PubMed ID: 18381934
[TBL] [Abstract][Full Text] [Related]
11. Erioflorin stabilizes the tumor suppressor Pdcd4 by inhibiting its interaction with the E3-ligase β-TrCP1.
Blees JS; Bokesch HR; Rübsamen D; Schulz K; Milke L; Bajer MM; Gustafson KR; Henrich CJ; McMahon JB; Colburn NH; Schmid T; Brüne B
PLoS One; 2012; 7(10):e46567. PubMed ID: 23056346
[TBL] [Abstract][Full Text] [Related]
12. RSK-mediated down-regulation of PDCD4 is required for proliferation, survival, and migration in a model of triple-negative breast cancer.
Cuesta R; Holz MK
Oncotarget; 2016 May; 7(19):27567-83. PubMed ID: 27028868
[TBL] [Abstract][Full Text] [Related]
13. Xanthohumol Promotes Skp2 Ubiquitination Leading to the Inhibition of Glycolysis and Tumorigenesis in Ovarian Cancer.
He YF; Liu YP; Liao JZ; Gan Y; Li X; Wang RR; Wang F; Zhou J; Zhou L
Am J Chin Med; 2024; 52(3):865-884. PubMed ID: 38790085
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer.
Chen Z; Yuan YC; Wang Y; Liu Z; Chan HJ; Chen S
Breast Cancer Res Treat; 2015 Jul; 152(1):29-39. PubMed ID: 26026468
[TBL] [Abstract][Full Text] [Related]
15. Skp2 stabilizes Mcl-1 and confers radioresistance in colorectal cancer.
Yu X; Zhou L; Liu W; Liu L; Gao F; Li W; Liu H
Cell Death Dis; 2022 Mar; 13(3):249. PubMed ID: 35301297
[TBL] [Abstract][Full Text] [Related]
16. Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2.
Wang G; Wang J; Chang A; Cheng D; Huang S; Wu D; Sirkisoon S; Yang S; Lin HK; Lo HW; Xiang R; Sun P
Oncogene; 2020 Nov; 39(47):7034-7050. PubMed ID: 32989258
[TBL] [Abstract][Full Text] [Related]
17. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
[TBL] [Abstract][Full Text] [Related]
18. Optimizing component formula suppresses lung cancer by blocking DTL-mediated PDCD4 ubiquitination to regulate the MAPK/JNK pathway.
Fan Q; Lu Q; Wang G; Zhu W; Teng L; Chen W; Bi L
J Ethnopharmacol; 2022 Dec; 299():115546. PubMed ID: 35850313
[TBL] [Abstract][Full Text] [Related]
19. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
[TBL] [Abstract][Full Text] [Related]
20. Deathproof: new insights on the role of skp2 in tumorigenesis.
Reed SI
Cancer Cell; 2008 Feb; 13(2):88-9. PubMed ID: 18242509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
